ABBV · News · 20260824N

Net Income and Profitability

AbbVie Inc. · 2026-08-24 · Importance 24 · Surprise 30

Q2 2026 adjusted diluted EPS rose 22.9% year over year to $3.65. The EPS increase accompanied 10.2% growth in net revenue to $16.990 billion. The reported earnings improvement was supported by Skyrizi and Rinvoq growth and a 20.3% increase in neuroscience revenue.

Key facts